Emergent BioSolutions
EBS
#6672
Rank
โ‚น62.34 B
Marketcap
โ‚น1,169
Share price
-2.99%
Change (1 day)
37.23%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: โ‚น62.34 Billion

As of January 2026 Emergent BioSolutions has a market cap of โ‚น62.34 Billion. This makes Emergent BioSolutions the world's 6672th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น62.34 B4.73%
2025โ‚น59.53 B54.86%
2024โ‚น38.44 B270.83%
2023โ‚น10.36 B-78.74%
2022โ‚น48.75 B-71.99%
2021โ‚น174.06 B-49.88%
2020โ‚น347.29 B74.61%
2019โ‚น198.90 B-6.28%
2018โ‚น212.22 B43.35%
2017โ‚น148.04 B63.81%
2016โ‚น90.37 B-13.74%
2015โ‚น104.77 B61%
2014โ‚น65.07 B25.11%
2013โ‚น52.01 B65.13%
2012โ‚น31.50 B-1.64%
2011โ‚น32.02 B-12.98%
2010โ‚น36.80 B89.31%
2009โ‚น19.44 B-48.23%
2008โ‚น37.55 B535.61%
2007โ‚น5.90 B-56.69%
2006โ‚น13.64 B

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Emergent BioSolutions was reported to be:

โ‚น61.37 Billion
by Nasdaq info icon info icon
โ‚น62.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
โ‚น24.894 T 39,828.83%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น42.68 B-31.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น9.182 T 14,628.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น164.05 B 163.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.063 T 20,852.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.311 T 5,211.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚น1.22 B-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA